Cogmedix and one of its clients, Convergent Dental are mentioned in the July/August issue of Biophotonics magazine. The article, “The Promise of Advanced Laser-Based Therapy,” discusses the rapid progress of medical lasers in numerous applications including drug delivery, oncology, gene therapy, nerve repair and dentistry. These recent technological developments have enabled safe and effective use of lasers in multiple settings.
Convergent Dental’s Solea is the first CO2 laser system cleared by the FDA for hard and soft tissue ablation. The device nearly eliminates the drill from dental procedures and is generally anesthesia-free. Convergent Dental recently chose Cogmedix to be its medical device contract manufacturer. Click here to read the full article. Read more about the Solea in the press release.